Skip to main content
Clinical Trials/JPRN-jRCTs042210124
JPRN-jRCTs042210124RecruitingPhase 3

Efficacy of endoscopic submucosal resection with ligation device for small rectal neuroendocrine tumor: an open-label randomized control trial

Imai Kenichiro0 sites266 target enrollmentStarted: January 6, 2022Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
Enrollment
266

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
>= 20age old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Patients with rectal neuroendocrine tumors of <=10 mm in size

Exclusion Criteria

  • Local recurrence after previous polypectomy attempts
  • Inflammatory bowel disease, polyposis syndrome
  • Hematological abnormality
  • Active infectious disease
  • Hemodialysis
  • Infeasibility of suspending antithrombotic drugs
  • Pregnant woman

Investigators

Sponsor
Imai Kenichiro

Similar Trials